2018
DOI: 10.5387/fms.2018-01
|View full text |Cite
|
Sign up to set email alerts
|

Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum

Abstract: Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is frequently associated with rapidly progressive interstitial lung disease (RP-ILD) resulting in high mortality. Here we report a 51-year-old Japanese woman with anti-MDA5 antibody-positive hypomyopathic dermatomyositis (DM) who developed RP-ILD. She developed respiratory failure and pneumomediastinum, however her RP-ILD responded favorably to the combined immunosuppressive treatments consisti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 22 publications
1
10
0
Order By: Relevance
“…In addition, we found upregulation of the genes produced during extracellular or intracellular dsRNA viral replication. Recently, several papers have documented the modulation of MDA5 in JDM muscle biopsies [ 60 ]. This molecule is like an intracellular pathogen sensor that is located in the cytosol, and belongs to the family of RIG-I-like receptors (RLRs), as well as RIG-I [ 61 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, we found upregulation of the genes produced during extracellular or intracellular dsRNA viral replication. Recently, several papers have documented the modulation of MDA5 in JDM muscle biopsies [ 60 ]. This molecule is like an intracellular pathogen sensor that is located in the cytosol, and belongs to the family of RIG-I-like receptors (RLRs), as well as RIG-I [ 61 ].…”
Section: Discussionmentioning
confidence: 99%
“…Dermatomyositis can be subclassified according to particular Abs, one of which is anti-melanoma differentiation-associated protein 5 (anti-MDA5), seen in 10-35% of cases [1]. Anti-MDA5 is reported to be an independent risk factor for interstitial lung disease-(ILD-) associated mortality [2]. Although typically associated with clinical amyopathic dermatomyositis (CADM), 42.9-54.5% anti-MDA5 patients can demonstrate overt clinical myopathy [1,3].…”
Section: Introductionmentioning
confidence: 99%
“…One patient presented with subjective proximal muscle weakness and had a normal CK level, while a second patient endorsed proximal muscle weakness and tenderness with an elevated CK. 3 , 4 Thus, anti-MDA5 antibody-associated dermatomyositis usually presents without myositis, but a spectrum of muscle involvement is possible.…”
Section: Discussionmentioning
confidence: 99%